Fast Five Quiz: Idiopathic Pulmonary Fibrosis Treatment

Guy W. Soo Hoo, MD, MPH; Zab Mosenifar, MD

Disclosures

May 12, 2022

In a study conducted by Birring and colleagues, it was suggested that the mechanism of cough in IPF might be disease specific. An inhaled cromolyn preparation was shown to ameliorate cough frequency in IPF patients, with relatively minor side effects.

Conventional antitussive therapy is not useful in the treatment of IPF.

Although low-dose corticosteroids are sometimes used daily and then tapered if benefit is conferred, no effect on quality of life or survival benefit has been shown, and side effects must be considered.

Thalidomide used for the treatment of cough in IPF has been shown to provide some improvement to quality of life, but potential adverse effects can be severe.

Learn more about the management of cough in IPF.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....